Gui Shuang Ying

Gui Shuang Ying

University of Pennsylvania - Philadelphia / United States
Medical and Health Sciences / Ophthalmology
AD Scientific Index ID: 1446996
person_outline Gui Shuang Ying's MOST POPULAR ARTICLES
1-) Ranibizumab and bevacizumab for neovascular age-related macular degeneration.DF Martin, MG Maguire, GS Ying, JE Grunwald, SL Fine, GJ JaffeThe New England journal of medicine 364 (20), 1897-1908, 201123222011
2-) Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsDF Martin, MG Maguire, SL Fine, G Ying, GJ Jaffe, JE Grunwald, C Toth, ...Ophthalmology 119 (7), 1388-1398, 20121885*2012
3-) Age-dependent effects of RPE65 gene therapy for Leber\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s congenital amaurosis: a phase 1 dose-escalation trialAM Maguire, KA High, A Auricchio, JF Wright, EA Pierce, F Testa, ...The Lancet 374 (9701), 1597-1605, 20099482009
4-) Gene therapy for Leber\'s congenital amaurosis is safe and effective through 1.5 years after vector administrationF Simonelli, AM Maguire, F Testa, EA Pierce, F Mingozzi, JL Bennicelli, ...Molecular Therapy 18 (3), 643-650, 20107292010
5-) Five-year outcomes with anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration …MG Maguire, DF Martin, G Ying, GJ Jaffe, E Daniel, JE Grunwald, CA Toth, ...Ophthalmology 123 (8), 1751-1761, 20166892016